Literature DB >> 17606885

Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene.

I Gourfinkel-An1, C Duyckaerts, A Camuzat, C Meyrignac, P Sonderegger, M Baulac, A Brice.   

Abstract

Familial encephalopathy with neuroserpin inclusion bodies is a recently described neurodegenerative disease that is responsible for progressive myoclonic epilepsy or presenile dementia. In a French family with the S52R mutation of the neuroserpin gene, progressive myoclonic epilepsy was associated with a frontal syndrome. The typical cerebral inclusions (Collins bodies) were abundant in the frontal cortex and in the head of the caudate nucleus but spared the cerebellum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17606885     DOI: 10.1212/01.wnl.0000265052.99144.b5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.

Authors:  Alessandro Orsini; Angelo Valetto; Veronica Bertini; Mariagrazia Esposito; Niccolò Carli; Berge A Minassian; Alice Bonuccelli; Diego Peroni; Roberto Michelucci; Pasquale Striano
Journal:  Seizure       Date:  2019-08-23       Impact factor: 3.184

2.  Encephalopathy with neuroserpin inclusion bodies presenting as progressive myoclonus epilepsy and associated with a novel mutation in the Proteinase Inhibitor 12 gene.

Authors:  Matthew C Hagen; Jill R Murrell; Marie-Bernadette Delisle; Eva Andermann; Frederick Andermann; Marie Christine Guiot; Bernardino Ghetti
Journal:  Brain Pathol       Date:  2011-03-24       Impact factor: 6.508

3.  pH-dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of beta-sheet A and polymerization.

Authors:  Didier Belorgey; Peter Hägglöf; Maki Onda; David A Lomas
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

4.  Identification of a neurovascular signaling pathway regulating seizures in mice.

Authors:  Linda Fredriksson; Tamara K Stevenson; Enming J Su; Margaret Ragsdale; Shannon Moore; Stefan Craciun; Gerald P Schielke; Geoffrey G Murphy; Daniel A Lawrence
Journal:  Ann Clin Transl Neurol       Date:  2015-05-01       Impact factor: 4.511

Review 5.  Neuroserpin: structure, function, physiology and pathology.

Authors:  Emanuela D'Acunto; Annamaria Fra; Cristina Visentin; Mauro Manno; Stefano Ricagno; Giovanna Galliciotti; Elena Miranda
Journal:  Cell Mol Life Sci       Date:  2021-08-17       Impact factor: 9.261

6.  Polymerogenic neuroserpin causes mitochondrial alterations and activates NFκB but not the UPR in a neuronal model of neurodegeneration FENIB.

Authors:  E D'Acunto; L Gianfrancesco; I Serangeli; M D'Orsi; V Sabato; N A Guadagno; G Bhosale; S Caristi; A V Failla; A De Jaco; E Cacci; M R Duchen; G Lupo; G Galliciotti; E Miranda
Journal:  Cell Mol Life Sci       Date:  2022-07-21       Impact factor: 9.207

Review 7.  Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Authors:  Gabor G Kovacs
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

Review 8.  Physiological and pathological roles of tissue plasminogen activator and its inhibitor neuroserpin in the nervous system.

Authors:  Tet Woo Lee; Vicky W K Tsang; Nigel P Birch
Journal:  Front Cell Neurosci       Date:  2015-10-13       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.